S'abonner

Lactate combined with SOFA score for improving the predictive efficacy of SOFA score in patients with severe heatstroke - 19/03/24

Doi : 10.1016/j.ajem.2024.01.033 
Fujing Liu a, 1, Fang Jin b, 1, Lingling Zhang c, Yun Tang d, Jinhai Wang a, He Zhang a, Tijun Gu a,
a Department of Emergency, The Affiliated Changzhou NO.2 People's Hospital of Nanjing Medical University, Changzhou City, Jiangsu Province, China 
b Department of Critical Care Medicine, The First People's Hospital of Kunshan, Suzhou City, Jiangsu Province, China 
c Department of Critical Care Medicine, The First People's Hospital of Nantong, Nantong City, Jiangsu Province, China 
d Department of Emergency and Critical Care Medicine, Jintan First People's Hospital, Changzhou City, Jiangsu Province, China 

Corresponding author.

Abstract

Background

The relationship between lactate levels and multiple organ dysfunction in patients with severe heatstroke remains unclear. In this study, we aimed to elucidate the clinical significance of lactate in severe heatstroke prognosis and assess whether incorporating lactate in the SOFA score improves its predictive efficacy.

Methods

This study was a multicenter retrospective cohort investigation included 275 patients. Logistic regression analysis was performed to examine the relationship between lactate levels and patient outcomes and complications, including acute kidney injury (AKI), disseminated intravascular coagulation (DIC), and myocardial injury. Further, receiver operating characteristic (ROC) curves and clinical decision curve analysis (DCA) were used to evaluate the predictive power of lactate and SOFA scores in severe heatstroke-associated death. Lastly, the Kaplan–Meier survival curve was employed to differentiate the survival rates among the various patient groups.

Results

After adjusting for confounding factors, lactate was demonstrated as an independent risk factor for death (OR = 1.353, 95% CI [1.170, 1.569]), AKI (OR = 1.158, 95% CI [1.007, 1.332]), DIC (OR = 1.426, 95% CI [1.225, 1.659]), and myocardial injury (OR = 2.039, 95% CI [1.553, 2.679]). The area under the curve (AUC) of lactate for predicting death from severe heatstroke was 0.7540, with a cutoff of 3.35. The Kaplan–Meier survival curve analysis showed that patients with elevated lactate levels had higher mortality rates. Additionally, the ROC curves demonstrated that combining lactate with the SOFA score provided better predictive efficacy than the SOFA score alone in patients with severe heatstroke (AUC: 0.9025 vs. 0.8773, DeLong test, P < 0.001). Finally, the DCA curve revealed a higher net clinical benefit rate for lactate combined with the SOFA score.

Conclusions

Lactate is an independent risk factor for severe heatstroke-related death as well as a risk factor for AKI, DIC, and myocardial injury associated with severe heatstroke. Thus, combining lactate with the SOFA score can significantly improve its predictive efficacy in patients with severe heatstroke.

Le texte complet de cet article est disponible en PDF.

Keywords : Severe heatstroke, Lactate, Prognosis, SOFA score


Plan


© 2024  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 78

P. 163-169 - avril 2024 Retour au numéro
Article précédent Article précédent
  • Combined modified Valsalva maneuver with adenosine supraventricular tachycardia: A comparative study
  • Lifeng Xiao, Xiaomin Ou, Wanshang Liu, Xiaorong Lin, Lin Peng, Shuyi Qiu, Qishuo Zhang
| Article suivant Article suivant
  • Assessing the precision of artificial intelligence in ED triage decisions: Insights from a study with ChatGPT
  • Sinan Paslı, Abdul Samet Şahin, Muhammet Fatih Beşer, Hazal Topçuoğlu, Metin Yadigaroğlu, Melih İmamoğlu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.